Lynde Langdon

Lynde is a WORLD Digital assistant editor and reports on popular and fine arts. She lives in Wichita, Kan., with her husband and two daughters. Follow Lynde on Twitter @lmlangdon.

Cloning's Piltdown man

Medicine | Following months of accusations, an investigation committee reports that Hwang Woo-Suk's research results were fabricated
by Lynde Langdon
Posted 1/28/06, 12:00 am

A 9-month-old Afghan hound named Snuppy can now claim more than just the title "World's First Cloned Dog." An investigation into the research of his engineer, South Korea's Hwang Woo-Suk, revealed Snuppy was also Mr. Hwang's only legitimate scientific discovery during the two years he lied to the world about astonishing achievements he never made.

Read more

What's a human?

Interview | Bioethicist and presidential advisor Leon Kass wants to get back to basics about medical science's complexities
by Lynde Langdon
Posted 1/28/06, 12:00 am

Leon Kass did not appoint himself shepherd of the rocky hills of modern-day bioethics. He set out with a one-year leave of absence from his biomedical research at the National Institutes of Health to explore bioethics 35 years ago. The young physician-scientist never made it back to the lab.

Instead, his thoughts and writings about the nature of human dignity became guideposts for a nation struggling to answer the question: What does it mean to be human?

Read more

Cell oversell

Medicine | November was not a good month for embryonic stem-cell research
by Lynde Langdon
Posted 12/10/05, 12:00 am

As editor Glenn McGee lamented on the American Journal of Bioethics weblog, November was not a good month for embryonic stem-cell research. An ethical breach tripped up the field's leading researcher while an embarrassed international scientific community watched. Meanwhile, research in ethical realms of science-those that do not depend on cloning and embryo destruction-continues to deliver groundbreaking therapies and offer further proof that you just don't have to kill embryos to save lives. Here are the latest developments:

Read more